Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis.
Gillessen S, Tombal B, Turco F, Choudhury A, Rodriguez-Vida A, Gallardo E, Velho PI, Nolè F, Cruz F, Loriot Y, McDermott R, Roumeguere T, Daugaard G, Yamamura R, Bompas E, Maroto P, Polo MH, da Trindade KM, Preto DD, Skoneczna I, Lecouvet F, Coens C, Fournier B, Saad F.
Gillessen S, et al. Among authors: choudhury a.
Eur Urol. 2025 Jan 17:S0302-2838(24)02747-7. doi: 10.1016/j.eururo.2024.11.027. Online ahead of print.
Eur Urol. 2025.
PMID: 39827019